Penn study identifies protein that could be key to new immunotherapies

Mortality goal based on applying outcomes among healthier segments to entire population

Advances in automation eliminate the tedious, time-consuming aspects of cell culture and cell line development

Even within the same tumor, cancer cells can differ in their genetics, behavior, and susceptibility to chemotherapy drugs

While new cases of most types of cancer are declining, those of melanoma—the deadliest form of skin cancer—continue to climb

A study presents a new, less expensive, and more accurate way to engineer and monitor immune system cancer therapies

Are we killing the cure?

Absorbent polymer sops up chemotherapy drugs from the bloodstream after treatment

A new drug delivery system could radically expand cancer treatment options